Literature DB >> 8379531

Fine-needle aspiration of Hürthle cell lesions. A cytomorphologic approach to diagnosis.

J L Gonzalez1, H H Wang, B S Ducatman.   

Abstract

Hürthle cells may be found in fine-needle aspirates of the thyroid (FNATs) from Hürthle cell tumors (HCTs) and nonneoplastic Hürthle cell lesions, including Hashimoto's thyroiditis and goiter. To differentiate the characteristic cytomorphologic features from these lesions, the authors studied 38 surgically excised Hürthle cell lesions of the thyroid. Preoperative FNATs were reviewed for a number of architectural and cytologic features. The chi-squared and Fisher's exact tests were used for statistical analysis. There were many statistically significant cytologic differences between HCTs and nonneoplastic Hürthle cell lesions. Statistically significant features indicating an HCT versus nonneoplastic Hürthle cell lesion included the following: a high percentage (> 90%) of Hürthle cells, single Hürthle cells (> 10%), cellular dyshesion, large nucleoli, significant nuclear pleomorphism, significant nuclear enlargement, absence of macrophages, absence of plasma cells, and absence of or few lymphocytes. The architecture of cell groups, cellularity, amount of colloid, and multinucleation appeared to be of no value. The presence of a high percentage of dyshesive Hürthle cells with large nucleoli, with some cells showing significant nuclear enlargement and pleomorphism, associated with a lack of lymphoplasmacytic inflammatory cells, appears statistically predictive of an HCT and should enable the differentiation of an HCT from a nonneoplastic Hürthle cell lesion.

Entities:  

Mesh:

Year:  1993        PMID: 8379531     DOI: 10.1093/ajcp/100.3.231

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Hürthle cell tumor of the thyroid: analysis of 188 cases.

Authors:  K Sugino; K Ito; T Mimura; K Kameyama; H Iwasaki; K Ito
Journal:  World J Surg       Date:  2001-09       Impact factor: 3.352

2.  [Analysis of diagnosis and treatment of 100 patients with Hürthle cell adenoma].

Authors:  Q Kang; J X Zhang; Y Gao; J Q Zhang; X H Guo
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

3.  Oncocytic cell tumors of the thyroid: factors predicting malignancy and influencing prognosis, treatment decisions, and outcomes.

Authors:  Adolfo Pisanu; Barbara Di Chiara; Isabella Reccia; Alessandro Uccheddu
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

4.  Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.

Authors:  Kristine S Wong; Vickie Y Jo; Alarice C Lowe; William C Faquin; Andrew A Renshaw; Akeesha A Shah; Michael H Roh; Edward B Stelow; Jeffrey F Krane
Journal:  Cancer Cytopathol       Date:  2019-11-21       Impact factor: 5.284

5.  CORRELATIONS BETWEEN THE PRESENCE OF HÜRTHLE CELLS AND CYTOMORPHOLOGICAL FEATURES OF FINE-NEEDLE ASPIRATION BIOPSY IN THYROID NODULES.

Authors:  M Stanciu; I S Zaharie; L G Bera; G Cioca
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Oct-Dec       Impact factor: 0.877

6.  A focal nodular Hürthle cell hyperplasia in Hashimoto's thyroiditis: A diagnostic dilemma on fine needle aspiration.

Authors:  Shirish S Chandanwale; Tanmayi V Kulkarni; Ruchir J Patel; Dhaval Thakkar
Journal:  J Cytol       Date:  2014 Oct-Dec       Impact factor: 1.000

7.  Typical manifestations of Hürthle cell adenoma of the thyroid on contrast-enhanced CT: A case report.

Authors:  Dayong Deng; Xi Chen; Hongru Wang; Haidi Wu
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

8.  Hürthle cell-predominant thyroid fine needle aspiration cytology: A four risk-factor model highly accurate in excluding malignancy and predicting neoplasm.

Authors:  Lisi Yuan; Christian Nasr; James F Bena; Tarik M Elsheikh
Journal:  Diagn Cytopathol       Date:  2022-06-08       Impact factor: 1.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.